Medical
NCCN Pleural Mesothelioma Guidelines 2025–2026: 4 Evidence Categories Explained
David Foster
June 1, 2026
How NCCN Guidelines rank pleural mesothelioma treatment across 4 evidence categories, and why nivolumab + ipilimumab is the only Category 1 first-line option.
10 min read 6 FAQs
Read